Chutes & Ladders—3 weeks after leaving bluebird, CMO Davidson lands at Tessera
Tyler Jacks, Ph.D., after 19 years. The director role will be taken over by Matthew Vander Heiden, M.D., Ph.D., a professor of biology at MIT and a medical oncologist at Dana-Farber Cancer Institute. He became a member of the Koch Institute in 2010 and took over for Jacks on Thursday, MIT said. Jacks will continue to lead the Bridge Project, which unites bioegnineers, cancer scientists and clinical oncologists from the Koch Institute and the Dana-Farber/Harvard Cancer Center. > Atara Biotherapeutics ushered Amie Krause into the role of senior vice president and chief people officer Apri...
Source: fiercebiotech.com